Beximco Pharmaceuticals Limited (AIM:BXP)
London · Delayed Price · Currency is GBP · Price in GBX 43.00
0.00 (0.00%)
Oct 31, 2025, 4:19 PM GMT+1
Beximco Pharmaceuticals Market Cap
Beximco Pharmaceuticals has a market cap or net worth of 319.22 million as of October 31, 2025. Its market cap has increased by 59.29% in one year.
Market Cap
319.22M
Enterprise Value
364.68M
Revenue
309.11M
Ranking
n/a
PE Ratio
7.53
Stock Price
43.00
Market Cap Chart
Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 22.96M to 319.22M, an increase of 1,290.23%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 324.38M | 33.81% |
| Dec 30, 2024 | 242.42M | -48.09% |
| Dec 28, 2023 | 466.99M | -11.21% |
| Dec 29, 2022 | 525.95M | -29.56% |
| Dec 30, 2021 | 746.62M | 1.29% |
| Dec 30, 2020 | 737.12M | 192.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |